Literature DB >> 4066768

Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts.

T Sejersen, J Sümegi, N R Ringertz.   

Abstract

Myoblasts from primary rat cultures and established mouse (Cl10) and rat (L6, Ama 420) cell lines were examined for c-oncogene expression during exponential growth and under conditions which allowed myogenic differentiation. The abundance of c-Ki-ras transcripts in mRNA from confluent, quiescent cultures was reduced to 15-40% of that in mRNA from exponentially growing cells. This reduction was found both in primary myoblast cultures, myoblast lines that formed myotubes (L6 and Cl10) and in a differentiation defective subline (Ama 420). The level of c-myc transcripts was lowered when myogenic rat L6 myoblasts reached a high cell density, stopped DNA synthesis and formed myotubes. At the same cell density, growth arrested myoblasts of differentiation defective Ama 420 cells maintained a high level of c-myc expression. This shows that DNA replication and c-myc expression are independently regulated. All myoblast lines also showed expression of c-abl during exponential growth phase. Reduced expression was seen in differentiated L6 and Cl10 cultures. No expression was detected when mRNA from multiplying and differentiating myoblasts cultures were probed for c-myb, c-erbA, c-erbB, c-mos, c-fes, and c-src. The observations are consistent with a role for c-Ki-ras in myoblast proliferation and suggest that a reduction in c-myc expression may be a necessary prerequisite for terminal myogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066768     DOI: 10.1002/jcp.1041250315

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  19 in total

1.  A point mutation in the MyoD basic domain imparts c-Myc-like properties.

Authors:  M E Van Antwerp; D G Chen; C Chang; E V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.

Authors:  A Zentella; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  A role for the putative tumor suppressor Bin1 in muscle cell differentiation.

Authors:  R J Wechsler-Reya; K J Elliott; G C Prendergast
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

Review 4.  Control of myogenic differentiation by cellular oncogenes.

Authors:  M D Schneider; E N Olson
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

5.  Proto-oncogene expression in proliferating and differentiating cardiac and skeletal muscle.

Authors:  W C Claycomb; N A Lanson
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

6.  Localization in situ of c-myc mRNA and c-myc protein in adult mouse testis.

Authors:  T Koji; S Izumi; M Tanno; T Moriuchi; P K Nakane
Journal:  Histochem J       Date:  1988-10

7.  Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation.

Authors:  M D Schneider; M B Perryman; P A Payne; G Spizz; R Roberts; E N Olson
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

8.  Dissociated expression of c-myc and a fos-related competence gene during cardiac myogenesis.

Authors:  M D Schneider; P A Payne; H Ueno; M B Perryman; R Roberts
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

9.  The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.

Authors:  E N Olson; G Spizz; M A Tainsky
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

10.  An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal.

Authors:  P A Payne; E N Olson; P Hsiau; R Roberts; M B Perryman; M D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.